首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN INDUCTION THERAPY FOR SMALL-CELL LUNG-CANCER - DOSE INTENSIFICATION
被引:0
|
作者
:
JOHNSON, DH
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
JOHNSON, DH
[
1
]
MANGUM, MD
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
MANGUM, MD
[
1
]
GRECO, FA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
GRECO, FA
[
1
]
机构
:
[1]
VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
来源
:
CLINICAL RESEARCH
|
1987年
/ 35卷
/ 01期
关键词
:
D O I
:
暂无
中图分类号
:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号
:
1001 ;
摘要
:
引用
收藏
页码:A26 / A26
页数:1
相关论文
共 50 条
[21]
ADDITION OF ETOPOSIDE TO CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE FOR REMISSION INDUCTION AND SURVIVAL IN PATIENTS WITH SMALL-CELL LUNG-CANCER
MESSEIH, AA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
MESSEIH, AA
SCHWEITZER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
SCHWEITZER, JM
LIPTON, A
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
LIPTON, A
HARVEY, HA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
HARVEY, HA
SIMMONDS, MA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
SIMMONDS, MA
STRYKER, JA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
STRYKER, JA
RICCI, JA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
RICCI, JA
HOFFMAN, SL
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
HOFFMAN, SL
GOTTLEIB, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
GOTTLEIB, RJ
DIXON, RH
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
DIXON, RH
SHOPE, ES
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
SHOPE, ES
MELOY, JH
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
MELOY, JH
WALKER, BK
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
WALKER, BK
GORDON, RA
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
GORDON, RA
HECKARD, R
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
HECKARD, R
WHITE, DS
论文数:
0
引用数:
0
h-index:
0
机构:
PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CHEM,DIV ONCOL,HERSHEY,PA 17033
WHITE, DS
CANCER TREATMENT REPORTS,
1987,
71
(01):
: 61
-
66
[22]
VINCRISTINE, DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH AND WITHOUT ETOPOSIDE IN LIMITED SMALL-CELL LUNG-CANCER
NIKKANEN, V
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
NIKKANEN, V
LIIPPO, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
LIIPPO, K
OJALA, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
OJALA, A
JAKOBSSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
JAKOBSSON, M
JARVINEN, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
JARVINEN, M
PALOHEIMO, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
PALOHEIMO, S
NORDMAN, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURKU,CENT HOSP,DEPT DIS CHEST,SF-20520 TURKU 52,FINLAND
NORDMAN, E
ACTA ONCOLOGICA,
1990,
29
(04)
: 421
-
424
[23]
ALTERNATING CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE (CAV) AND CISPLATIN ETOPOSIDE (PVP) AGAINST SMALL-CELL LUNG-CANCER
BANDO, H
论文数:
0
引用数:
0
h-index:
0
BANDO, H
TAKISHITA, Y
论文数:
0
引用数:
0
h-index:
0
TAKISHITA, Y
OGURA, T
论文数:
0
引用数:
0
h-index:
0
OGURA, T
SONE, S
论文数:
0
引用数:
0
h-index:
0
SONE, S
SHIMIZU, E
论文数:
0
引用数:
0
h-index:
0
SHIMIZU, E
NAKAYAMA, T
论文数:
0
引用数:
0
h-index:
0
NAKAYAMA, T
DOI, H
论文数:
0
引用数:
0
h-index:
0
DOI, H
KOBAYASHI, M
论文数:
0
引用数:
0
h-index:
0
KOBAYASHI, M
JAPANESE JOURNAL OF CLINICAL ONCOLOGY,
1991,
21
(06)
: 435
-
439
[24]
CARBOPLATIN ETOPOSIDE IN SMALL-CELL LUNG-CANCER
BISHOP, JF
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
BISHOP, JF
ARIYOSHI
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
ARIYOSHI
KUNITO
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
KUNITO
JOHNSON, DH
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
JOHNSON, DH
ONCOLOGY,
1992,
49
: 11
-
18
[25]
ORAL ETOPOSIDE IN SMALL-CELL LUNG-CANCER
COMIS, RL
论文数:
0
引用数:
0
h-index:
0
COMIS, RL
SEMINARS IN ONCOLOGY,
1986,
13
(03)
: 75
-
78
[26]
ORAL ETOPOSIDE IN SMALL-CELL LUNG-CANCER
CARNEY, DN
论文数:
0
引用数:
0
h-index:
0
CARNEY, DN
KEANE, M
论文数:
0
引用数:
0
h-index:
0
KEANE, M
GROGAN, L
论文数:
0
引用数:
0
h-index:
0
GROGAN, L
SEMINARS IN ONCOLOGY,
1992,
19
(06)
: 40
-
44
[27]
EVALUATION OF HIGH-DOSE ETOPOSIDE COMBINED WITH CISPLATIN FOR TREATING RELAPSED SMALL-CELL LUNG-CANCER
MASUDA, N
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
MASUDA, N
FUKUOKA, M
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
FUKUOKA, M
MATSUI, K
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
MATSUI, K
NEGORO, S
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
NEGORO, S
TAKADA, M
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
TAKADA, M
SAKAI, N
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
SAKAI, N
RYU, S
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
RYU, S
TAKIFUJI, N
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
TAKIFUJI, N
ITO, K
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
ITO, K
KUDOH, S
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
KUDOH, S
KUSUNOKI, Y
论文数:
0
引用数:
0
h-index:
0
机构:
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
OSAKA PREFECTURAL HABIKINO HOSP,DEPT INTERNAL MED,3-7-1 HABIKINO,HABIKINO,OSAKA 583,JAPAN
KUSUNOKI, Y
CANCER,
1990,
65
(12)
: 2635
-
2640
[28]
INTENSIFICATION OF SMALL-CELL LUNG-CANCER CHEMOTHERAPY
JOHNSON, DH
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,NASHVILLE,TN 37232
VANDERBILT UNIV,NASHVILLE,TN 37232
JOHNSON, DH
GRECO, FA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,NASHVILLE,TN 37232
VANDERBILT UNIV,NASHVILLE,TN 37232
GRECO, FA
CANCER INVESTIGATION,
1986,
4
(05)
: 506
-
507
[29]
CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE AS 1ST-LINE THERAPY IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
BUNN, PA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
BUNN, PA
GRECO, FA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
GRECO, FA
EINHORN, L
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,MED CTR,SCH MED,DIV MED ONCOL,NASHVILLE,TN 37232
EINHORN, L
SEMINARS IN ONCOLOGY,
1986,
13
(03)
: 45
-
53
[30]
CISPLATIN VERSUS CISPLATIN PLUS ETOPOSIDE IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER
KLASTERSKY, J
论文数:
0
引用数:
0
h-index:
0
KLASTERSKY, J
SCULIER, JP
论文数:
0
引用数:
0
h-index:
0
SCULIER, JP
BUREAU, G
论文数:
0
引用数:
0
h-index:
0
BUREAU, G
LIBERT, P
论文数:
0
引用数:
0
h-index:
0
LIBERT, P
RAVEZ, P
论文数:
0
引用数:
0
h-index:
0
RAVEZ, P
VANDERMOTEN, G
论文数:
0
引用数:
0
h-index:
0
VANDERMOTEN, G
THIRIAUX, J
论文数:
0
引用数:
0
h-index:
0
THIRIAUX, J
LECOMTE, J
论文数:
0
引用数:
0
h-index:
0
LECOMTE, J
CORDIER, R
论文数:
0
引用数:
0
h-index:
0
CORDIER, R
DABOUIS, G
论文数:
0
引用数:
0
h-index:
0
DABOUIS, G
BROHEE, D
论文数:
0
引用数:
0
h-index:
0
BROHEE, D
THEMELIN, L
论文数:
0
引用数:
0
h-index:
0
THEMELIN, L
MOMMEN, P
论文数:
0
引用数:
0
h-index:
0
MOMMEN, P
JOURNAL OF CLINICAL ONCOLOGY,
1989,
7
(08)
: 1087
-
1092
←
1
2
3
4
5
→